Memphis Pharmaceuticals (MPCI.CA) - Disclosure Form for the BoD & the Shareholders' Structure
Company Name : Memphis Pharmaceuticals
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
The company sent its Disclosure Form for the BoD & the shareholders' structure for the period ended 31/12/2023, according to Article 30 of the Listing Rules.
The Disclosure Form (287 KB)
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
The company sent its Disclosure Form for the BoD & the shareholders' structure for the period ended 31/12/2023, according to Article 30 of the Listing Rules.
The Disclosure Form (287 KB)
Comments